Tandem Health has raised $100 million in Series B funding, bringing its total raised to $160 million. The round was led by Scaleup Europe Fund, managed by EQT, with support from existing investors including Kinnevik, Northzone, Amino Collective, and Visionaries Club. This infusion of cash is expected to fund product development, market penetration, and talent acquisition across the firm’s European footprint.
The company develops AI-powered tools for European healthcare, including an AI scribe that converts clinical conversations into structured notes, a coding assistant, dictation tools, and clinical decision support. Its platform supports medicine, mental health, nursing, social services, physiotherapy, and dentistry, giving clinicians a single interface for tasks that were previously scattered across separate applications. Tandem Health serves 10,000 care organizations across 14 European markets.
Dr. Katie Baker, UK director of the firm, emphasized the importance of clinician adoption over procurement. “Clinical AI succeeds or fails on adoption,” she said. She added that the company is investing in scale, deepening its presence in existing markets, and growing its clinical team of more than 75 clinicians as it moves toward an AI-native clinic operating system.
In the past six months, the organization secured EU MDR Class IIa certification for three medical devices. The Clinical Decision Support tool, certified in June, provides patient-specific answers to clinical questions during visits. The AI Medical Scribe, certified in May, transcribes clinician-patient discussions into reviewable clinical notes. In February, the Coding Assistant received certification for automating diagnosis and procedure code suggestions. These approvals demonstrate compliance with strict European regulatory standards and enable wider deployment in hospitals and clinics.
In addition, the firm acquired Juvoly, a Dutch AI medical scribe, in January. The deal combined Juvoly’s expertise in Dutch primary care, hospitals, and municipalities with the broader European platform, creating a more robust data set for language models and expanding the company’s reach into the Benelux region.
Competitors in the space include Nabla (France), Tortus (UK), Corti (Denmark), and Heidi Health (Australia, now expanding in Europe). Most focus on reducing administrative burdens, such as ambient documentation and note generation, though some have extended into workflows like coding and decision support. The competitive field highlights a shared belief that automation can free clinicians to concentrate on patient care.
